No.52203186/National Natural Science Foundation of China[Grants and Funding] - Search Results

Save citations to file

Your saved search

Your RSS Feed

Page 1

Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer.

Hao Q, Dai L, Chang L, Song D, Liu D, Ma X, Wu H, Kang H. Hao Q, et al. Sci Rep. 2024 Aug 5;14(1):18055. doi: 10.1038/s41598-024-68719-7. Sci Rep. 2024. PMID: 39103475 Free PMC article.

Revitalizing Bacillus Calmette-Guérin Immunotherapy for Bladder Cancer: Nanotechnology and Bioengineering Approaches.

Lv M, Shang S, Liu K, Wang Y, Xu P, Song H, Zhang J, Sun Z, Yan Y, Zhu Z, Wu H, Li H. Lv M, et al. Pharmaceutics. 2024 Aug 15;16(8):1067. doi: 10.3390/pharmaceutics16081067. Pharmaceutics. 2024. PMID: 39204412 Free PMC article. Review.

Impact of response to neoadjuvant chemotherapy on surgical modality in patients with T1-2N0-1M0 triple-negative breast cancer.

Chang L, Liu D, Hao Q, Ren X, Liu P, Liu X, Wei Y, Lin S, Ma X, Wu H, Kang H, Wang M. Chang L, et al. J Cancer Res Clin Oncol. 2024 Aug 1;150(8):378. doi: 10.1007/s00432-024-05907-y. J Cancer Res Clin Oncol. 2024. PMID: 39085623 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters